HGH is growth hormone itself, injected. MK-677 (ibutamoren) is an oral compound that prompts your pituitary gland to release more of its own growth hormone. That one difference drives everything else: how each is taken, how strongly it acts, what it costs your body’s glucose control, and how it is regulated in Canada. If you want the signalling route to growth hormone, the better question is which secretagogue-style peptide fits your goal, and we cover that in our guide to peptides for growth hormone.
TL;DR
- HGH (somatropin) is the hormone itself. MK-677 is a ghrelin-receptor agonist that raises your own GH and IGF-1 by taking the pituitary’s signal.
- In a 2008 two-year trial, MK-677 raised fat-free mass by 1.1 kg versus a 0.5 kg loss on placebo, but strength and function did not improve.
- Both can reduce insulin sensitivity and raise blood glucose, so glucose control is the main safety point to understand.
- In Canada, Health Canada has not authorized MK-677 and warns against products claiming to contain it, while HGH is a prescription drug.
Table of Contents
- What each one is and how it works
- How strongly does MK-677 raise growth hormone?
- Muscle, fat and recovery: what trials show
- Safety: glucose, appetite and water retention
- Where each stands in Canada
- Which should you choose?
- Our view
- Explore our range
- FAQ
- Sources
What each one is and how it works
Growth hormone is made by somatotroph cells in the anterior pituitary, the gland at the base of the brain. It is released in pulses and acts directly on tissues (protein synthesis, fat breakdown) and indirectly by prompting the liver to make IGF-1, according to a 2025 clinical review. Because IGF-1 lasts longer in the blood than GH, clinicians use it as a stand-in for GH levels.
HGH (somatropin) is that hormone given directly, by injection. The dose you give is the dose that arrives.
MK-677 (ibutamoren) works upstream. It activates the ghrelin receptor, the same one the hunger hormone uses, and the pituitary responds by releasing more of its own GH. It amplifies the natural pulses rather than replacing them. Reviews of this drug class describe these molecules as designed for once-daily oral dosing to restore a young-adult GH profile.
| HGH (somatropin) | MK-677 (ibutamoren) | |
|---|---|---|
| What it is | The hormone itself | Oral GH secretagogue |
| How it is taken | Injection | Once daily by mouth |
| Where it acts | Directly on tissue and via IGF-1 | Pituitary, then IGF-1 |
| Pulsatile release | Bypassed | Preserved and amplified |
| Canadian status | Prescription drug | Not authorized by Health Canada |
How strongly does MK-677 raise growth hormone?
Strongly enough to show up in blood work. In a 1996 trial of 32 healthy people aged 64 to 81, 25 mg a day raised average 24-hour GH by 97% and lifted IGF-1 from 141 to 265 µg/L over four weeks, into the young-adult range. A Belgian study in young men found that seven days of bedtime dosing increased the frequency of GH pulses and raised IGF-1 in a dose-dependent way.

Forum threads often claim 25 mg equals a specific number of IU of HGH. No trial in the research we reviewed supports a dose-for-dose conversion, so treat those figures as guesses. What the trials do show is a sustained rise in IGF-1, which is the number that links to most of the effects people want.
Muscle, fat and recovery: what trials show
The best long-term data is a two-year randomized trial of 65 healthy adults aged 60 to 81 taking 25 mg daily:
- GH and IGF-1 rose to the levels of healthy young adults.
- Fat-free mass increased 1.1 kg versus a 0.5 kg loss on placebo.
- Body weight rose 2.7 kg versus 0.8 kg.
- Strength and function did not change.
In obese men over eight weeks, IGF-1 rose about 40% and fat-free mass increased, while total and visceral fat did not change significantly. The same group saw a modest improvement in cholesterol ratios. A 2017 review summarizes secretagogues as improving lean mass, appetite, bone turnover and sleep, with safety data limited by short, small studies.
What this means for you: MK-677 reliably moves GH and IGF-1 and adds lean mass, and the sleep and recovery effects are the ones most people notice. Do not expect it to be a fat-loss tool on its own, and gains in lean mass in these trials did not translate to measured strength. Pairing it with training is what turns tissue changes into performance. If your goal is building lean mass with training, our peptides for muscle growth guide lays out the options.
If you want to understand how body-composition changes relate to real-world function, this resource on creatine and bone loading is a useful companion on strength and structure.
Safety: glucose, appetite and water retention
The same trials that show the benefits show the trade-offs, and you should know them before choosing any GH-axis approach.
- Glucose. In the two-year trial, fasting glucose rose 0.3 mmol/L and insulin sensitivity declined. In the 1996 trial, fasting glucose rose from 5.4 to 6.8 mmol/L at four weeks.
- Appetite. 67% of MK-677 users reported increased appetite versus 36% on placebo, which eased within a few months.
- Fluid and muscle. Mild lower-limb swelling (44% vs 27%) and muscle pain (33% vs 9%) were reported.
- Heart. A hip-fracture trial in 123 elderly patients was stopped early after 4 patients on ibutamoren developed congestive heart failure versus 1 on placebo.
People with diabetes or prediabetes, with heart failure or fluid retention, with a history of cancer, or who are pregnant should not use these compounds without a physician. Anyone using them should have fasting glucose monitored. The US Get Smart About Drugs page also notes MK-677 remains investigational.
Prescription HGH carries its own cautions. The Canadian product monograph for Nutropin says somatropin should not be used with any evidence of tumour activity or active diabetic retinopathy, and that it can induce insulin resistance, so glucose is monitored periodically. For a wider look at weighing diabetes risk against treatment, see this guide to long-term weight loss options.
Where each stands in Canada
HGH is a prescription drug in Canada, prescribed by a physician for diagnosed deficiency. MK-677 has no Canadian authorization. Health Canada’s bodybuilding-products page lists ibutamoren among drugs claiming to be SARMs and advises anyone taking such products to stop and speak with a health care provider. A December 2025 advisory described seized unauthorized HGH and injectable peptides and noted that selling unauthorized health products in Canada is illegal.
In practice: talk to your physician before anything that changes your GH axis, and use a physician’s guidance for any prescription HGH.
Which should you choose?
| Your priority | Better fit |
|---|---|
| Diagnosed GH deficiency | Prescription HGH under a physician |
| Understanding GH-axis support without injecting the hormone | Secretagogue peptides such as GHRH and GHRP types |
| Sleep and recovery | Secretagogues, which preserve natural pulses |
| Tight glucose control | Discuss with your physician first |
Secretagogue peptides share MK-677’s logic of prompting your own GH release. Our guides cover GHRH peptides and GHRP-6, and the broader HGH and peptides overview explains how they compare.
Our view
We think the useful question is not which compound is stronger but which route to growth hormone fits your goal and your body. Signalling your pituitary to release its own GH keeps the natural pulsatile pattern, and that is the logic behind the peptides we supply for muscle growth, recovery and anti-aging.
Quality matters as much as the compound. Our products are backed by third-party lab certificates of analysis, with purity above 99% through advanced purification methods. Know exactly what you are using, track your glucose and sleep, and work with your physician.
Pure Peptide
Explore our range
We supply high-purity peptides for muscle growth, recovery, weight loss and anti-aging, along with ancillaries such as bacteriostatic water, syringes and alcohol pads. Browse the full range on our shop or start with peptides for recovery.
FAQ
Is MK-677 as strong as HGH?
MK-677 raises GH and IGF-1 into young-adult ranges in trials, but it works through your pituitary rather than supplying the hormone directly. No trial supports an exact IU equivalence, so comparisons you see online are estimates.
Does MK-677 boost growth hormone?
Yes. In a 1996 trial, 25 mg daily raised average 24-hour GH by 97% and IGF-1 from 141 to 265 µg/L over four weeks.
Does MK-677 build muscle?
In a two-year trial it increased fat-free mass by 1.1 kg versus a loss on placebo, though strength and function did not measurably change. Training remains what converts lean mass into performance.
What are the main side effects?
Increased appetite, mild swelling in the legs, muscle pain and higher fasting glucose were reported. People with diabetes, heart failure or a cancer history should speak with their physician first.
Is MK-677 approved in Canada?
No. Health Canada has not authorized it and advises people taking products claiming to contain it to consult a health care provider.
Sources
- Growth hormone and aging: a clinical review (2025)
- The Safety and Efficacy of Growth Hormone Secretagogues (2017)
- Development of Growth Hormone Secretagogues, Endocrine Reviews (2005)
- Chapman et al., 1996 MK-677 trial
- Copinschi et al., 1996 MK-677 study
- Nass et al., 2008 two-year trial
- Svensson et al., 1998 trial in obese men
- Svensson et al., 1999 lipoprotein trial
- Get Smart About Drugs: MK-677 risks (2025)
- Nutropin product monograph, Health Canada database
- Health Canada: Using bodybuilding products
- Health Canada advisory, December 2025